Novel transcript, antisense to RFTN2 (ENSG00000294165)

This locus encodes a long non-coding RNA transcribed on the strand opposite to the RFTN2 gene, annotated as ENSG00000294165. Evidence for widespread antisense transcription in the human genome suggests such transcripts frequently regulate their sense counterparts' expression via several mechanisms: transcriptional interference, affecting chromatin signatures, altering transcript stability, and modulating sense transcript production rates[1][2][4][6]. Antisense lncRNAs are not typical drug targets and rarely act as receptors, enzymes, or classical disease targets. There is currently no direct functional or clinical annotation for this specific antisense transcript beyond its genomic definition[5]. This entry is not considered a therapeutic target (i.e., not a receptor, enzyme, transporter), but rather a poorly characterized antisense lncRNA. There is no evidence for interacting drugs, biomarker use, or defined disease role at this time. It may play a regulatory role in the expression of RFTN2 via antisense RNA-mediated mechanisms as established for related transcripts[1][2][4][6].

None known for drugs; as an antisense RNA, may modulate sense transcript (RFTN2) expression through chromatin alteration, transcriptional interference, or RNA masking